Pericarditis
📧 Sign up to get email alerts when something new happens for Pericarditis.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2016-12-22FDA Approved: COLCRYS — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
FDA approved a supplemental application for COLCRYS (colchicine) from Takeda Pharmaceuticals America, Inc., indicating changes to its labeli…
-
CLINICAL_TRIALS research · 2016-04-28Clinical Trial Update: Prognostic Biomarkers in Patients With Acute Pericarditis
A clinical study is investigating prognostic biomarkers in patients with acute pericarditis.
-
FDA approval · 2016-01-25FDA Approved: COLCRYS — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
The FDA approved a supplemental application for COLCRYS (colchicine) filed by Takeda Pharmaceuticals America, expanding or updating the drug…
-
FDA approval · 2015-12-17FDA Approved: COLCRYS — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
The FDA approved a supplemental application for COLCRYS (colchicine) submitted by Takeda Pharmaceuticals America, Inc.
-
FDA approval · 2014-09-26FDA Approved: MITIGARE — Original Application (Hikma Specialty USA Inc.)
FDA approved the Mitigare brand of colchicine (Hikma Specialty USA Inc.) through an Original Application. This establishes a labeled colchic…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2014-08-14FDA Approved: COLCRYS — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
FDA approves a supplemental application for COLCRYS (colchicine) submitted by Takeda Pharmaceuticals America, Inc. The supplemental approval…
-
CLINICAL_TRIALS trial_result · 2014-05-30Clinical Trial Update: Apolipoprotein CIII Reduction Via Colchicine [EARLY_Phase 1]
An early-phase trial completed evaluating colchicine as a strategy to reduce apolipoprotein CIII in hypertriglyceridemia. The study also rel…
-
CLINICAL_TRIALS trial_result · 2013-08-07Clinical Trial Update: Study of Colchicine to Treat and Prevent Recurrent Pericarditis After Failure of Conventional Treatment. [Phase 4]
Phase 4 clinical trial assessing colchicine for treating and preventing recurrent pericarditis after conventional treatment failure has comp…
-
CLINICAL_TRIALS trial_result · 2012-06-07Clinical Trial Update: Study of Colchicine to Treat Acute Pericarditis and Prevent Recurrences [Phase 3]
This document reports the completion of a Phase 3 trial evaluating colchicine for treating acute pericarditis and preventing recurrences.
-
CLINICAL_TRIALS trial_result · 2011-12-21Clinical Trial Update: Benign Acute Pericarditis: Brief Versus Longer Treatment Using Aspirin [Phase 4]
Phase 4 trial comparing brief versus longer aspirin treatment for benign acute pericarditis has been terminated.
-
CLINICAL_TRIALS trial_result · 2011-02-16Clinical Trial Update: Study of Colchicine to Treat and Prevent Recurrent Pericarditis (First Episode) [Phase 3]
A Phase 3 clinical trial evaluating colchicine to treat and prevent recurrent pericarditis (first episode) has completed.
-
FDA approval · 2010-09-30FDA Approved: ARCALYST — Supplemental Application (Kiniksa Pharmaceuticals (UK), Ltd.)
The FDA approved a supplemental application for ARCALYST (rilonacept) by Kiniksa Pharmaceuticals (UK), Ltd., updating the existing approval.
-
FDA approval · 2010-04-29FDA Approved: COLCRYS — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
FDA approved a supplemental application for Colcrys (colchicine) submitted by Takeda Pharmaceuticals America, Inc.
-
CLINICAL_TRIALS research · 2010-02-05Clinical Trial Update: Noise, a Risk for Heart in Airplane Pilots
A clinical trial update from Universidad Politecnica de Madrid investigating whether noise affects heart health in airplane pilots, with per…